Home > Boards > US Listed > Medical - Equipment > Accuray Inc. (ARAY)

Accuray rises premarket as 4Q orders improve

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
surf1944 Member Profile
 
Followed By 438
Posts 24,509
Boards Moderated 1
Alias Born 09/11/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 6:56:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 4:02:51 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/30/2019 4:03:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 9:26:06 AM
Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology... PR Newswire (US) - 5/1/2019 4:10:00 PM
Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System PR Newswire (US) - 4/24/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2019 4:06:35 PM
Accuray Reports Fiscal 2019 Third Quarter Results PR Newswire (US) - 4/23/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2019 5:02:00 PM
Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019 PR Newswire (US) - 4/2/2019 7:30:00 AM
Bilkent City Hospital Selects Accuray's Radixact® System PR Newswire (US) - 3/14/2019 11:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2019 5:02:18 PM
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with ... PR Newswire (US) - 2/22/2019 7:30:00 AM
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with ... PR Newswire (US) - 2/22/2019 7:30:00 AM
Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors GlobeNewswire Inc. - 2/20/2019 4:06:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 5:26:03 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2019 3:56:30 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2019 10:24:25 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2019 8:51:58 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2019 3:50:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/8/2019 6:20:30 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/4/2019 10:21:32 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/31/2019 6:41:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/28/2019 7:02:17 AM
Accuray And China Isotope And Radiation Corporation Enter Joint Venture Contract To Manufacture And Sell Radiation Oncology S... PR Newswire (US) - 1/28/2019 6:00:00 AM
surf1944   Wednesday, 08/28/13 10:43:38 AM
Re: surf1944 post# 1205
Post # of 1222 
Accuray rises premarket as 4Q orders improve
Accuray rises after company says radiation therapy system orders got better in 4th quarter

Associated PressAssociated Press – 1 hour 15 minutes ago

NEW YORK (AP) -- Shares of Accuray climbed in premarket trading Wednesday after the radiation-treatment equipment maker said new orders are improving.
Accuray reported its fiscal fourth-quarter results after the market closed on Tuesday. Its loss narrowed from a year ago despite a decline in revenue. Net new product orders rose 32 percent from last year, and the company said its backlog has grown over the last three months and is larger than it was a year ago.
Accuray shares picked up 50 cents, or 8.2 percent, to $6.60 in premarket trading.
The Sunnyvale, Calif., company sells radiation therapy systems under the names CyberKnife and TomoTherapy. Accuray said it took a loss of $18.7 million, or 25 cents per share, over the three months ended June 30. Accuray Inc. took a loss of $20.3 million, or 28 cents per share, a year earlier.
If one-time items are excluded the company said it lost 20 cents per share in the fourth quarters of fiscal 2013 and 2012. Revenue fell 16 percent, to $84.9 million from $100.5 million.
Analysts were expecting a loss of 20 cents per share on $84.3 million in revenue, according to FactSet.
Jefferies & Co. analyst Raj Denhoy said Accuray is moving in the right direction because orders are increasing and the company is getting better at keeping its costs under control. He kept a "Buy" rating on the stock and raised his price target to $8 per share from $6.50.
Accuray said it lost $103.2 million, or $1.41 per share, in fiscal 2013 after losing $72 million, or $1.02 per share, the year before. Revenue fell 23 percent, to $316 million from $409.2 million.
The company expects to report $325 million to $345 million in revenue in fiscal 2014. Analysts estimate $359.6 million on average.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist